Naproxen
Title: Naproxen
CAS Registry Number: 22204-53-1
CAS Name: (aS)-6-Methoxy-a-methyl-2-naphthaleneacetic acid
Additional Names: d-2-(6-methoxy-2-naphthyl)propionic acid; MNPA
Manufacturers' Codes: RS-3540
Trademarks: Bonyl (Erco); Dysmenalgit (Krewel); Equiproxen (Syntex); Floginax (Lifepharma); Laraflex (Lagap); Laser (Tosi); Malexin (BASF); Naixan (Tanabe); Napren (Nycomed); Naprius (Magis); Naprosyn (Syntex); Naprosyne (Syntex); Naprux (Andromaco); Naxen (Syntex); Nycopren (Nycomed); Pranoxen (Napp); Prexan (Lafare); Proxen (Syntex); Proxine (Del Saz & Filippini); Veradol (Schering AG); Xenar (Alfa)
Molecular Formula: C14H14O3
Molecular Weight: 230.26
Percent Composition: C 73.03%, H 6.13%, O 20.85%
Literature References: Nonsteroidal anti-inflammatory. Prepn: J. H. Fried, I. T. Harrison, ZA 6707597; eidem, US 3904682; eidem, US 4009197 (1968, 1975, 1977 all to Syntex); I. T. Harrison et al., J. Med. Chem. 13, 203 (1970). Pharmacology: Roszkowski et al., J. Pharmacol. Exp. Ther. 179, 114 (1971). Activity may be due to the ability to inhibit prostaglandin biosynthesis. Mode of action studies: Tomlinson et al., Biochem. Biophys. Res. Commun. 46, 552 (1972). Metabolism: Runkel et al., J. Pharm. Sci. 61, 703 (1972). HPLC determn in plasma and serum: P. J. Streete, J. Chromatogr. 495, 179 (1989). Stereoselective synthesis: K. T. Wan, M. E. Davis, Nature 370, 449 (1994). Clinical studies: Katona et al., Clin. Trials J. 8, 3 (1972); Runkel, Chem. Pharm. Bull. 20, 1457 (1972). Review: Arzneim.-Forsch. 25, 278-332 (1975). Review of pharmacology and therapeutic efficacy: R. N. Brogden et al., Drugs 18, 241-277 (1979). Comprehensive description: F. J. Al-Shammary et al., Anal. Profiles Drug Subs. Excip. 21, 345-373 (1992).
Properties: Crystals from acetone-hexane, mp 152-154°. [a]D +66° (in chloroform). Sol in 25 parts ethanol (96%), 20 parts methanol, 15 parts chloroform, 40 parts ether. Practically insol in water. LD50 in mice (mg/kg): 435 i.v.; 1234 orally; in rats (mg/kg): 575 i.p.; 534 orally (Roszkowski).
Melting point: mp 152-154°
Optical Rotation: [a]D +66° (in chloroform)
Toxicity data: LD50 in mice (mg/kg): 435 i.v.; 1234 orally; in rats (mg/kg): 575 i.p.; 534 orally (Roszkowski)
 
Derivative Type: Piperazine salt
CAS Registry Number: 70981-66-7
Additional Names: Piproxen
Trademarks: Numidan (Coop. Farm.)
Molecular Formula: (C14H14O3)2.C4H10N2
Molecular Weight: 546.65
Percent Composition: C 70.31%, H 7.01%, O 17.56%, N 5.12%
 
Derivative Type: Sodium salt
CAS Registry Number: 26159-34-2
Manufacturers' Codes: RS-3650
Trademarks: Aleve (Procter & Gamble); Anaprox (Syntex); Antalgin (Syntex); Apranax (Syntex); Axer Alfa (Alfa); Flanax (Syntex); Gynestrel (Recordati); Miranax (Syntex); Naprelan (Wyeth-Ayerst); Primeral (Master); Synflex (Recordati)
Molecular Formula: C14H13NaO3
Molecular Weight: 252.24
Percent Composition: C 66.66%, H 5.19%, Na 9.11%, O 19.03%
Properties: Crystals from acetone, mp 244-246°. [a]D -11° (in methanol).
Melting point: mp 244-246°
Optical Rotation: [a]D -11° (in methanol)
 
Therap-Cat: Anti-inflammatory; analgesic; antipyretic.
Therap-Cat-Vet: Anti-inflammatory.
Keywords: Analgesic (Non-Narcotic); Anti-inflammatory (Nonsteroidal); Arylpropionic Acid Derivatives; Antipyretic.

Others monographs:
Ribonucleic AcidChlorbenzoxamineChlorogenic AcidHexamethylolmelamine
PlegatilLonapaleneIndoraminIndiplon
DihydrostreptomycinObidoxime ChlorideIxodinPotassium Ferricyanide
GlaucarubinMizoribineTelbivudineOil of Fleabane
©2016 DrugLead US FDA&EMEA